Researchers at the K N Toosi University of Technology in Tehran, Iran have developed an ultrasonic-powered microfluidic chip that can accurately separate circulating tumour cells (CTCs) from red blood cells. This breakthrough could lead to the early detection of cancer and pave the way for personalized medicine, real-time molecular analysis, and point-of-care diagnostics.
Forecast for 6 months: Within the next 6 months, we can expect to see the refinement of the design of the ultrasonic-powered chip, aiming for a portable device that can be operated with a small battery pack in resource-limited and remote environments.
Forecast for 1 year: In the next 1 year, we anticipate the widespread adoption of this technology in clinical settings, with the first clinical trials commencing to evaluate the efficacy of the chip in detecting cancer.
Forecast for 5 years: Within the next 5 years, we predict that the ultrasonic-powered chip will become a standard tool in cancer diagnosis, with thousands of devices being used worldwide to detect and monitor cancer patients.
Forecast for 10 years: In the next 10 years, we foresee the development of even more advanced technologies that build upon the principles of the ultrasonic-powered chip, leading to the early detection and treatment of cancer, and potentially even the prevention of cancer.
